Trial Site Detail
Drug: |
IMC-A12 |
|||
|---|---|---|---|---|
Trial: |
A Phase II Study of IMC-A12 in Children With Relapsed/Refractory Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Does not allow GIST |
|||
UCSF Helen Diller Family Comprehensive Cancer Center1450 3rd St. |
Principal Investigator: |
|
|---|---|
Contact: |
Clinical Trials Office - UCSF Helen Diller Family Comprehensive 877-827-3222 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
UCSF Helen Diller Family Comprehensive Cancer Center Website: |
https://clinicaltrials.ucsf.edu/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.